Join
Live feed
·
INSIDERFilingvia Quantisnow
Cyteir Therapeutics Inc. logo

SEC Form 4: Zakrzewski Joseph S bought $1,976 worth of shares (200 units at $9.88), increasing direct ownership by 0.25% to 81,167 units

ByQuantisnow·Wall Street's wire, on your screen.
CYT· Cyteir Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYT (Cyteir Therapeutics Inc.) and more on Quantisnow.